- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/06 - Antimalarials
Patent holdings for IPC class A61P 33/06
Total number of patents in this class: 1248
10-year publication summary
|
47
|
50
|
69
|
69
|
88
|
77
|
64
|
77
|
57
|
43
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10173 |
22 |
| The Walter and Eliza Hall Institute of Medical Research | 162 |
22 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3010 |
20 |
| Mmv Medicines for Malaria Venture | 31 |
19 |
| Centre National de La Recherche Scientifique | 11059 |
17 |
| Glaxosmithkline Intellectual Property Development Limited | 780 |
17 |
| BioNTech SE | 809 |
16 |
| The Johns Hopkins University | 5913 |
14 |
| The Regents of the University of California | 20815 |
13 |
| Institut Pasteur | 778 |
13 |
| University of Washington | 2453 |
12 |
| MSD R & D (China) Co. LTD. | 56 |
12 |
| Merck Sharp & Dohme LLC | 3737 |
12 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3275 |
11 |
| Merck Patent GmbH | 5735 |
10 |
| University of South Florida | 1903 |
9 |
| Atreca, Inc. | 54 |
9 |
| Griffith University | 160 |
9 |
| Latvian Institute of Organic Synthesis | 52 |
9 |
| University of Central Florida Research Foundation, Inc. | 1253 |
9 |
| Other owners | 973 |